Hironori Sagara

6.5k total citations · 1 hit paper
144 papers, 3.0k citations indexed

About

Hironori Sagara is a scholar working on Physiology, Pulmonary and Respiratory Medicine and Immunology. According to data from OpenAlex, Hironori Sagara has authored 144 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 84 papers in Physiology, 76 papers in Pulmonary and Respiratory Medicine and 22 papers in Immunology. Recurrent topics in Hironori Sagara's work include Asthma and respiratory diseases (75 papers), Respiratory and Cough-Related Research (31 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers). Hironori Sagara is often cited by papers focused on Asthma and respiratory diseases (75 papers), Respiratory and Cough-Related Research (31 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (17 papers). Hironori Sagara collaborates with scholars based in Japan, United States and United Kingdom. Hironori Sagara's co-authors include Takeshi Fukuda, Akihiko Tanaka, Yoshimichi Okayama, Tetsuya Homma, Hirohisa Saito, Chisei Ra, Koichi Andō, Sohei Makino, Sojiro Kusumoto and Ko Okumura and has published in prestigious journals such as New England Journal of Medicine, SHILAP Revista de lepidopterología and The Journal of Immunology.

In The Last Decade

Hironori Sagara

129 papers receiving 3.0k citations

Hit Papers

Mepolizumab for Eosinophilic Chronic Obstructive Pulmonar... 2017 2026 2020 2023 2017 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Mepolizumab for Eosinophilic Chronic Obstructive Pulmonary Disease
    2017 384 citations Ian Pavord, Huib A.M. Kerstjens et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hironori Sagara Japan 26 1.5k 1.2k 672 477 447 144 3.0k
Monique Henket Belgium 25 1.4k 0.9× 1.4k 1.1× 692 1.0× 516 1.1× 264 0.6× 105 2.7k
Seung‐Hyo Lee South Korea 24 761 0.5× 730 0.6× 900 1.3× 680 1.4× 300 0.7× 67 2.8k
Tania Maes Belgium 37 1.7k 1.1× 1.4k 1.1× 1.4k 2.2× 774 1.6× 462 1.0× 87 4.0k
Takayuki Ohtoshi Japan 31 826 0.5× 975 0.8× 680 1.0× 402 0.8× 291 0.7× 44 2.9k
Akira Kanda Japan 23 845 0.6× 355 0.3× 550 0.8× 546 1.1× 444 1.0× 100 2.4k
C. Magnus Sköld Sweden 30 750 0.5× 1.1k 0.9× 575 0.9× 677 1.4× 132 0.3× 65 2.8k
Christopher Grainge Australia 29 1.2k 0.8× 1.6k 1.3× 601 0.9× 476 1.0× 137 0.3× 86 2.8k
Adam Collison Australia 25 799 0.5× 646 0.5× 961 1.4× 831 1.7× 243 0.5× 84 2.7k
Joachim Lundahl Sweden 29 724 0.5× 521 0.4× 818 1.2× 325 0.7× 560 1.3× 131 2.6k
James Lordan United Kingdom 26 1.1k 0.7× 1.8k 1.4× 629 0.9× 366 0.8× 285 0.6× 78 3.3k

Countries citing papers authored by Hironori Sagara

Since Specialization
Citations

This map shows the geographic impact of Hironori Sagara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hironori Sagara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hironori Sagara more than expected).

Fields of papers citing papers by Hironori Sagara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hironori Sagara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hironori Sagara. The network helps show where Hironori Sagara may publish in the future.

Co-authorship network of co-authors of Hironori Sagara

This figure shows the co-authorship network connecting the top 25 collaborators of Hironori Sagara. A scholar is included among the top collaborators of Hironori Sagara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hironori Sagara. Hironori Sagara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fukuda, Y, Nobuyuki Horita, Masaharu Aga, et al.. (2024). Efficacy and safety of macrolide therapy for adult asthma: A systematic review and meta-analysis. Respiratory Investigation. 62(2). 206–215. 5 indexed citations
2.
Boulet, Louis‐Philippe, Carl Abbott, Guy Brusselle, et al.. (2024). Baseline Characteristics and ICS/LAMA/LABA Response in Asthma: Analyses From the CAPTAIN Study. The Journal of Allergy and Clinical Immunology In Practice. 12(5). 1244–1253.e8. 2 indexed citations
3.
Fukuda, Y, Tetsuya Homma, & Hironori Sagara. (2023). Clinical inertia in asthma. npj Primary Care Respiratory Medicine. 33(1). 34–34. 4 indexed citations
4.
Zyl-Smit, Richard N. van, Kenneth R. Chapman, Huib A.M. Kerstjens, et al.. (2023). Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with Asthma. Journal of Asthma and Allergy. Volume 16. 123–134.
5.
6.
7.
Homma, Tetsuya, et al.. (2021). Mepolizumab improved airway hyperresponsiveness in a patient with allergic bronchopulmonary aspergillosis. Asian Pacific Journal of Allergy and Immunology. 4 indexed citations
8.
Andō, Koichi, Yasunari Kishino, Tetsuya Homma, et al.. (2020). Nivolumab plus Ipilimumab versus Existing Immunotherapies in Patients with PD-L1-Positive Advanced Non-Small Cell Lung Cancer: A Systematic Review and Network Meta-Analysis. Cancers. 12(7). 1905–1905. 16 indexed citations
9.
Hirai, Kuniaki, Tetsuya Homma, Hiroki Sato, et al.. (2020). Usefulness of Ninjin'yoeito for Chronic Obstructive Pulmonary Disease Patients with Frailty. The Journal of Alternative and Complementary Medicine. 26(8). 750–757. 13 indexed citations
10.
11.
12.
Fukuda, Y, et al.. (2019). Cutaneous metastases of lung cancer. SHILAP Revista de lepidopterología. 7(9). 1796–1797. 3 indexed citations
13.
Ohta, Shin, Akihiko Tanaka, Yoshitaka Uchida, et al.. (2019). The effect of muscarinic M3 receptor blockage in development of M2 macrophages in allergic inflammation. Journal of Allergy and Clinical Immunology. 143(2). AB293–AB293. 3 indexed citations
14.
Fukuda, Y, Tetsuya Homma, Shintaro Suzuki, et al.. (2018). High burden of Aspergillus fumigatus infection among chronic respiratory diseases. Chronic Respiratory Disease. 15(3). 279–285. 12 indexed citations
15.
Uchida, Masaru, Hiroshi Shiraishi, Shoichiro Ohta, et al.. (2012). Periostin, a Matricellular Protein, Plays a Role in the Induction of Chemokines in Pulmonary Fibrosis. American Journal of Respiratory Cell and Molecular Biology. 46(5). 677–686. 139 indexed citations
16.
Sagara, Hironori, et al.. (2008). Effect of Oral Procaterol in Combination with Inhaled Corticosteroids in Adult Patients with Bronchial Asthma. 35(3). 153–159. 1 indexed citations
17.
Sagara, Hironori, Kazumi Akimoto, Takenori Okada, et al.. (2007). Interleukin-10 Regulates Transforming Growth Factor-β Signaling in Cultured Human Bronchial Epithelial Cells. Respiration. 74(4). 454–459. 12 indexed citations
18.
Nakao, Atsuhito, Hironori Sagara, Yasuhiro Setoguchi, et al.. (2002). Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. Journal of Allergy and Clinical Immunology. 110(6). 873–878. 52 indexed citations
19.
Sagara, Hironori, Ko Okumura, Hideoki Ogawa, et al.. (2002). Activation of TGF-β/Smad2 signaling is associated with airway remodeling in asthma. Journal of Allergy and Clinical Immunology. 110(2). 249–254. 109 indexed citations
20.
Coward, William R., Yoshimichi Okayama, Hironori Sagara, et al.. (2002). NF-κB and TNF-α: A Positive Autocrine Loop in Human Lung Mast Cells?. The Journal of Immunology. 169(9). 5287–5293. 110 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Monique Henket Breakdown of academic impact, for papers by Seung‐Hyo Lee Breakdown of academic impact, for papers by Tania Maes Breakdown of academic impact, for papers by Takayuki Ohtoshi Breakdown of academic impact, for papers by Akira Kanda Breakdown of academic impact, for papers by C. Magnus Sköld Breakdown of academic impact, for papers by Christopher Grainge Breakdown of academic impact, for papers by Adam Collison Breakdown of academic impact, for papers by Joachim Lundahl Breakdown of academic impact, for papers by James Lordan
Rankless by CCL
2026